GE Healthcare Believes It Has 'Game-Changer' for Cell Analysis Market | GenomeWeb

By Tony Fong

NEW YORK (GenomeWeb News) – With its planned purchase of Applied Precision, GE Healthcare expects to enter into a new and fast-growing segment of the cellular imaging space with technology that a GE official called a "game-changer."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.